DJO® Acquires LiteCure Laser Therapy
December 11 2020 - 8:00AM
Business Wire
Acquisition establishes Chattanooga® as the
leader in high-power laser therapy
DJO, LLC (“DJO” or the “Company”), a leading global provider of
medical technologies to get and keep people moving, today announced
the acquisition of LiteCure®, the market leader in therapeutic
laser technology for human and animal health. This purchase
further extends DJO’s strength as the global market leader in
recovery sciences and allows the company to deliver unparalleled
innovation to its customers and their patients.
“The LiteCure portfolio was a natural fit for the DJO Recovery
Sciences business, bringing together a joint passion for innovation
and clinically proven technology,” said Brady Shirley, DJO CEO.
“The acquisition will strengthen our leadership position in
physical therapy and rehabilitation – and reinforces our commitment
to keeping people active; enabling our customers to better serve
their patients.”
DJO has long respected LiteCure’s reputation as the market
leader in laser light therapy and identified immediate synergies
with its Chattanooga rehabilitation business. “The LiteCure
portfolio complements and expands Chattanooga’s innovative
rehabilitation therapies,” said Terry Ross, President, DJO Recovery
Sciences. “Together, we will bring leading technologies and
treatment modalities designed to enhance patient outcomes and
practice efficiency to our customers around the world.”
LiteCure’s products are marketed under the brand names of
LightForce® Therapy Lasers for humans and Companion® for animals,
which includes Pegasus® equine laser technology.
LightForce is the industry leader in medical therapy
laser manufacturing and innovation, and continually seeks to move
the industry forward through laser science, technology, and
solutions. LightForce Therapy Lasers can be found in over 250
professional and college athletic training rooms and are the
preferred modality when treating world-class athletes. With
positive clinical results, high power lasers are one of the fastest
growing modalities in physical therapy.
In addition, the Companion brand provides a strong entry
point into the thriving animal health space and brings with it an
accomplished, dedicated animal health team. DJO plans to leverage
parts of its existing product portfolio to create an immediate
impact in animal health while working with the team to explore
incremental growth opportunities.
“With DJO’s expanded reach and resources, we are excited to
increase awareness and adoption of deep tissue laser therapy,”
added Brian Pryor, Founder and CEO of LiteCure. “We are passionate
about the clinical benefits of photobiomodulation as well as the
benefits it brings to a practice when adding this modality.”
For more information, visit djoglobal.com/LiteCure, or contact
your local sales representative.
About DJO®
DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a
leading developer and distributor of high-quality medical devices
that provide proven solutions for musculoskeletal health, joint
reconstruction, vascular health, and pain management. The Company’s
extensive range of products and integrated technologies address the
orthopedic continuum of care from performance and mobility to
surgical intervention and post-operative rehabilitation; enabling
people around the world to regain or maintain their natural motion.
For additional information about DJO, please visit
www.DJOGlobal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201211005129/en/
Brittany Knudson Brittany.knudson@djoglobal.com 760.681.7785
Colfax (NYSE:CFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Colfax (NYSE:CFX)
Historical Stock Chart
From Apr 2023 to Apr 2024